Patients often present with resistance to the initiation of an injectable agent
Your GP or specialist weight management service will review your complete medical history, including: The reason for cholecystectomy and time since surgery Any ongoing post-surgical symptoms or complications Current medications and potential drug interactions Presence of other gastrointestinal conditions Liver function and metabolic health status History of pancreatitis or pancreatic disease Pregnancy status or plans (GLP-1 RAs are contraindicated in pregnancy and breastfeeding) Baseline investigations typically include blood tests to assess liver function, kidney function, HbA1c (for diabetes screening), and lipid profile
Patient-specific factors Choice of GLP-1 medication also depends on certain factors like the presence of renal or hepatic issues, history of severe gastrointestinal side effects (gallstones, severe stomach pain, and pancreatitis), blood sugar levels, and weight loss goals
Glucose-6-Phosphate Dehydrogenase in Cataracts of Subjects Suffering from Favism
Revita has obtained FDA Breakthrough Device designation for post-GLP-1 weight maintenance, underscoring the urgency of the medical problem
Dushay says